Oct 9 (Reuters) - HHS:
* BIDEN-HARRIS ADMINISTRATION TAKES NEXT STEP ON PROPOSED MODEL TO LOWER PRESCRIPTION DRUG COSTS FOR PEOPLE WITH MEDICARE
* HHS: CMS SEEKS FEEDBACK ON MEDICARE $2 DRUG LIST MODEL, SAMPLE $2 DRUG LIST, AND OUTREACH
* HHS: PARTICIPATION IN MODEL WOULD BE VOLUNTARY FOR PART D SPONSORS & COULD START AS EARLY AS JAN 2027
* HHS: CMS INTENDS TO INCLUDE MANY DRUGS USED TO TREAT COMMON CONDITIONS FOR PEOPLE WITH MEDICARE, WITH PERIODIC UPDATES TO DRUG LIST ONCE FINALIZED
* HHS: NEW GENERIC DRUG LAUNCHES, CHANGING CLINICAL INDICATIONS, TRENDS IN PRICING TO NECESSITATE UPDATES TO $2 DRUG LIST, PRIOR TO LAUNCH OF MODEL
* HHS: NEW GENERIC DRUG LAUNCHES, CHANGING CLINICAL INDICATIONS, TRENDS IN PRICING TO NECESSITATE UPDATES TO $2 DRUG LIST AT INTERVALS IN MODEL LIFESPAN
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。